Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02167464 · ClinicalTrials.gov registry record · NA
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
A NA study of Hypertension, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 8
- Study locations
NCT02167464 is a NA study of Hypertension that has completed, run by Medical University of South Carolina. The registered enrollment target is 70 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 8 study locations across 1 state.
The verdict
NCT02167464, a NA study of Hypertension, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 8
- Study locations
Study Summary
Comparative Effectiveness Research using an intent-to-treat approach in 8 clinics in South Carolina. The investigators will assess 4 efficacious approaches to controlling treatment-resistant hypertension (TRH): Aldosterone Antagonist, Referral to Hypertension Specialist, Renin Treatment-Guided Therapeutics, and combination of Hypertension Specialist and Renin Treatment-Guided Therapeutics. Patients with TRH are evaluated with the BpTRU device for an accurate and representative blood pressure measure on two occasions before entry into the study. Qualitative data from focus group discussions with practice staff, and patient surveys and interviews will provide contextual data to help explain why some interventions are more acceptable and successful than others.
Conditions Studied
Interventions
- DRUG Renin treatment-guided Therapeutics
- OTHER Referral Hypertension specialist
- DRUG Aldosterone Antagonist
Study Locations (8)
South Carolina
- AnMed - Anderson
- Beaufort Jasper Hampton Comprehensive Health - Beaufort
- McLeod Family Medicine Center - Florence
- Family Diagnostics - Holly Hill
- Lovelace Family Medicine - Prosperity
- Carolina Medical Affiliates - Spartanburg
- Spartanburg Regional Health Services - Spartanburg
- Palmetto Primary Care - Summerville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2011-06 |
| Est. Completion | 2015-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02167464
The ClinicalTrials.gov registry entry for NCT02167464 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Renin treatment-guided Therapeutics is the first listed.
NCT02167464 reports 8 study locations spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT02167464 about?
NCT02167464 is a clinical study titled "Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study". Comparative Effectiveness Research using an intent-to-treat approach in 8 clinics in South Carolina. The investigators will assess 4 efficacious approaches to controlling treatment-resistant hypertension (TRH): Aldosterone Antagonist, Referral to Hypertension Specialist, Renin Treatment-Guided Thera...
What is the current status of trial NCT02167464?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2011-06. Estimated completion is 2015-01.
What conditions does trial NCT02167464 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT02167464?
The interventions under investigation include: Renin treatment-guided Therapeutics (DRUG), Referral Hypertension specialist (OTHER), Aldosterone Antagonist (DRUG).
Who is sponsoring clinical trial NCT02167464?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02167464 being conducted?
This trial has 8 study locations across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.